Press coverage about Invitae Corporation (NYSE:NVTA) has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Invitae Corporation earned a coverage optimism score of 0.07 on Accern’s scale. Accern also gave headlines about the medical research company an impact score of 45.8768937315036 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Here are some of the headlines that may have impacted Accern’s analysis:

Several analysts recently weighed in on NVTA shares. BidaskClub downgraded Invitae Corporation from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. J P Morgan Chase & Co restated an “overweight” rating and set a $15.00 target price (up previously from $14.00) on shares of Invitae Corporation in a research note on Wednesday, August 9th. Zacks Investment Research upgraded Invitae Corporation from a “sell” rating to a “hold” rating in a research report on Friday, August 11th. Finally, Leerink Swann reduced their price objective on Invitae Corporation from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Tuesday, November 7th. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $13.50.

Shares of Invitae Corporation (NYSE NVTA) opened at $8.65 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.61 and a current ratio of 2.61. Invitae Corporation has a 52-week low of $2.35 and a 52-week high of $8.68.

COPYRIGHT VIOLATION NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Invitae Corporation (NVTA) Stock Price” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at

Invitae Corporation Company Profile

Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients.

Receive News & Ratings for Invitae Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invitae Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.